Search Within

Gregory J Riely

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (118)
  2. Meeting Abstract (94)
  3. Book Section (6)
  4. Research Letter (1)
Groups
  1. Department of Medicine (219)
  2. GSK Faculty (219)
  3. Human Oncology and Pathogenesis Program (219)
  4. Solid Tumor Oncology Division (219)
  5. Thoracic Oncology (219)
  6. Department of Pathology and Laboratory Medicine (203)

More Groups

People
  1. Marc Ladanyi (187)
  2. Mark Kris (128)
  3. Maria Arcila (78)
  4. Helena Yu (65)
  5. Charles Rudin (61)
  6. Natasha Rekhtman (50)

More People

Years
  1. 2024 (10)
  2. 2023 (18)
  3. 2022 (12)
  4. 2021 (15)
  5. 2020 (14)
  6. 2019 (19)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. Journal of Thoracic Oncology (33)
  3. Clinical Cancer Research (30)
  4. JCO Precision Oncology (9)
  5. Annals of Oncology (8)
  6. Cancer Research (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (68)
  2. American Association for Cancer Research (48)
  3. Elsevier Inc. (35)
  4. Nature Publishing Group (13)
  5. Oxford University Press (11)
  6. Elsevier Science, Inc. (9)

More Publishers

Results (219)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HER2 amplification: A potential mechanism of acquired resistance to egfr inhibition in EGFR -mutant lung cancers that lack the second-site EGFR T790M mutation
    Journal Article

    Takezawa, K.; Pirazzoli, V.; Arcila, M. E.; Nebhan, C. A.; Song, X.; de Stanchina, E.; Ohashi, K.; Janjigian, Y. Y.; Spitzler, P. J.; Melnick, M. A.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C. S.; Ang, D.; Dogan, S.; Miller, V. A.; Ladanyi, M.; Kris, M. G.; Riely, G. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers
    Journal Article

    Dogan, S.; Shen, R.; Ang, D. C.; Johnson, M. L.; D'Angelo, S. P.; Paik, P. K.; Brzostowski, E. B.; Riely, G. J.; Kris, M. G.; Zakowski, M. F.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
    Journal Article

    Ohashi, K.; Sequist, L. V.; Arcila, M. E.; Moran, T.; Chmielecki, J.; Lin, Y. L.; Pan, Y.; Wang, L.; de Stanchina, E.; Shien, K.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2012)

    Fulltext@MSK | Save
  • ALK-rearranged lung cancer: Adenosquamous lung cancer masquerading as pure squamous carcinoma
    Journal Article

    Chaft, J. E.; Rekhtman, N.; Ladanyi, M.; Riely, G. J.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling
    Journal Article

    Chaft, J. E.; Arcila, M. E.; Paik, P. K.; Lau, C.; Riely, G. J.; Pietanza, M. C.; Zakowski, M. F.; Rusch, V.; Sima, C. S.; Ladanyi, M.; more...
    Molecular Cancer Therapeutics (2012)

    Fulltext@MSK | Save
  • Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
    Journal Article

    Girard, N.; Sima, C. S.; Jackman, D. M.; Sequist, L. V.; Chen, H.; Yang, J. C. H.; Ji, H.; Waltman, B.; Rosell, R.; Taron, M.; more...
    European Respiratory Journal (2012)

    Fulltext@MSK | Save
  • Clinical, pathologic, and molecular characteristics of patients with non-small cell lung cancer harboring mutations in PIK3CA
    Meeting Abstract

    Pietanza, M. C.; Arcila, M. E.; Chaft, J. E.; Zakowski, M. F.; Ladanyi, M.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Response to EGFR TKIs in never smokers with stage IV EGFR mutant squamous cell carcinoma of the lung (SQCC)
    Meeting Abstract

    Paik, P. K.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Incorporation of crizotinib into the NCCN guidelines
    Journal Article

    Riely, G. J.; Chaft, J. E.; Ladanyi, M.; Kris, M. G.
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save